# Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea

> **NCT03351114** · PHASE2 · COMPLETED · sponsor: **Duke University** · enrollment: 8 (actual)

## Conditions studied

- Morphea

## Interventions

- **DRUG:** Crisaborole

## Key facts

- **NCT ID:** NCT03351114
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-01
- **Primary completion:** 2020-03-10
- **Final completion:** 2020-03-10
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2021-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03351114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03351114, "Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03351114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*